$13.90 0.04 (+0.29%)
11/6/2009 4:00 PM

Savient Pharmaceuticals, Inc. (SVNT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Current Price $13.90 Mkt Cap $856.55M
Open $13.75 P/E Ratio 10.04
Prev. Close $13.86 Div. (Yield) N/A (N/A)
Daily Range $13.60 - $14.38 Volume 827,009
52-Wk Range $2.98 - $16.62 Avg. Daily Vol. 2,187,000

SVNT News and Commentary

Caps

How do you think SVNT will perform vs the S&P 500?

Add Stock to Watchlist

All Members

326 Outperform
34 Underperform
 

All-Star Members

63 Outperform
11 Underperform
 

Wall Street

12 Outperform
4 Underperform
 

Top SVNT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cjwBioPharma (88.78)
Submitted June 26, 2008

Puricase serves a clear need in treatment-failure gout. The product treats a highly symptomatic disease whose sufferers are traditionally affluent and have healthcare willing to accept higher than Wall Street estimate prices for drugs treating… More

0 Comments | Reply | Report this Post

zzlangerhans (99.36)
Submitted June 13, 2009

A very curious development today in Savient, which requires familiarity with FDA approval procedures as well as the history of this particularly interesting baby biotech to understand. I was at one point very confused about the approval process after… More

5 Comments | Reply | Report this Post
SVNT VS S&P 500 (SPY)

Fools bullish on SVNT are also bullish on:

Fools bearish on SVNT are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about SVNT.

Recs

0
Member Avatar cashsage (60.05) Submitted: 10/27/2009 5:23:11 AM : Underperform Start Price: $13.32 SVNT Score: -4.26

SVNT has a too high valuation compared to its sales potential. It is also loss making at least until 2011.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar spundun (68.07) Submitted: 10/8/2009 6:43:07 PM : Outperform Start Price: $14.24 SVNT Score: -2.85

HT BB

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar innojo (23.35) Submitted: 8/5/2009 2:30:30 PM : Outperform Start Price: $12.61 SVNT Score: +3.05

check out news on their new drug for gout --

Report this Post 0 Comments | Reply | Permalink
View All 58 Pitches »

Leaderboard

Find the members with the highest scoring picks in SVNT.

Score Leader

anggogo

anggogo (94.15) Score: +345.11

The Score Leader is the member with the highest score across all their picks in SVNT.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
anggogo 94.15 10/27/2008 Outperform 5Y $2.96 +369.59% +24.48% +345.11
lost402 96.67 10/27/2008 Outperform 5Y $3.03 +358.75% +25.59% +333.15
BlueInsight 85.91 10/28/2008 Outperform 5Y $3.27 +325.08% +25.17% +299.91
embodiedheart 97.11 10/28/2008 Outperform 5Y $3.27 +325.08% +25.17% +299.91
pdt24 < 20 10/28/2008 Outperform 5Y $3.27 +325.08% +25.17% +299.91
ashman225 85.00 3/2/2009 Outperform 3Y $4.19 +231.74% +50.34% +181.40
jss1199 < 20 11/17/2008 Outperform 3M $4.64 +199.57% +27.41% +172.15
TMFJacoby < 20 5/2/2006 Outperform 1Y $5.51 +152.27% -12.99% +165.26
NETREDNU 98.75 5/11/2009 Outperform NS $5.00 +178.00% +18.04% +159.96
LexTNZorro 75.94 5/11/2009 11/5/2009 Outperform 3M $5.00 +178.00% +18.04% +159.96 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackOppenheimer 26.63 10/10/2009 Outperform NS $14.24 -2.39% +0.46% -2.85
TrackJefferies 75.83 8/4/2009 Underperform NS $12.10 +14.88% +7.66% -7.21
TrackJMP < 20 6/17/2009 Outperform NS $12.32 +12.82% +18.18% -5.36
TrackWallStreetA 69.33 6/15/2009 Outperform NS $9.25 +50.27% +16.80% +33.47
TrackWedbush < 20 6/10/2009 Outperform NS $6.11 +127.50% +15.41% +112.09
TrackRothCapital 75.81 12/19/2008 Outperform NS $4.64 +199.57% +22.36% +177.21
TrackLeerinkSwan 84.26 11/25/2008 Outperform NS $4.20 +230.95% +25.80% +205.15
TrackOppenheimer 26.63 11/25/2008 Underperform NS $4.20 +193.33% +6.28% -187.06 6/17/2009 @ $12.32
TrackCowenandCo 74.62 10/27/2008 Underperform NS $6.70 +107.46% +27.84% -79.62
TrackCollinsStew 68.32 10/20/2008 Outperform NS $12.10 +14.88% +15.16% -0.29
TrackJefferies 75.83 4/1/2008 Outperform NS $20.42 +18.71% -6.13% +24.84 8/4/2008 @ $24.24
TrackDawsonJames 29.19 12/13/2007 Outperform NS $17.90 -22.35% -24.20% +1.85
TrackCitigroup 21.22 11/28/2007 Outperform NS $12.65 +9.88% -22.16% +32.04
TrackCreditSuiss 91.16 10/3/2007 Outperform NS $14.80 -6.08% -27.03% +20.95
TrackJimCramer < 20 9/27/2007 Underperform 3W $15.26 -8.91% -26.68% -17.77
TrackCowenandCo 74.62 9/21/2007 Outperform NS $13.40 -50.00% -41.74% -8.26 10/27/2008 @ $6.70
TrackFerrisBaker 72.41 3/29/2007 Outperform NS $12.00 +15.83% -20.54% +36.38
TrackLazardCapit < 20 2/2/2007 Outperform NS $15.00 -7.33% -21.43% +14.10
TrackJimCramer < 20 1/5/2007 Outperform 3W $11.66 +30.87% +8.98% +21.89 9/28/2007 @ $15.26
TrackJimCramer < 20 12/5/2006 Underperform 3W $11.84 -1.52% -0.36% +1.16 1/6/2007 @ $11.66
TrackWainwright < 20 10/25/2006 Underperform NS $7.29 +90.67% -17.47% -108.15

Featured Broker Partners